Alzheimer’s disease (AD) eventually leads to severe cognitive decline, but most affected individuals also develop distressing neuropsychiatric symptoms. These earlier effects may be more subtle…
Life expectancy for individuals with Down syndrome has grown in recent decades, thanks in large part to progress in patient care and treatment. But with…
Low levels of folate (vitamin B9) in the blood may be linked to a heightened risk of dementia and death from any cause in older…
Researchers have identified amyloid beta (Aβ) detected in blood to originate from peripheral tissues, and that the peptide acts on pancreaticβ-cells to suppress insulin secretion,…
You regularly can’t remember where you left your phone or your book. You keep missing appointments. You often lose your train of thought during conversation.
Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from…
Suppression of Fli-1 protects against pericyte loss, could be new therapeutic target for Alzheimer’s
Alzheimer’s disease is an enormous problem that, with an aging population, will only become bigger. More than 6 million Americans are living with Alzheimer’s disease,…
A Johns Hopkins Medicine study of about 50 people with Alzheimer’s disease has added to evidence that damage to the inner ear system that controls…
The University of Kentucky’s Sanders-Brown Center on Aging has been around for nearly half a century. In that time, they have built an international reputation…
Mild cognitive impairment (MCI) is considered the preclinical stage in progressive cognitive decline leading to the clinical stage of dementia. A study published in the…